Latest Articles
New Insights and Open Questions on Dietary and Lifestyle Approaches to Preventing Endometrial Cancer - BIOENGINEER.ORG
New Insights and Open Questions on Dietary and Lifestyle Approaches to Preventing Endometrial Cancer BIOENGINEER.ORG
Published: Aug. 8, 2025, 4:19 a.m.
New Insights and Open Questions on Dietary and Lifestyle Approaches to Preventing Endometrial Cancer - Bioengineer.org
New Insights and Open Questions on Dietary and Lifestyle Approaches to Preventing Endometrial Cancer Bioengineer.org
Published: Aug. 8, 2025, 4:19 a.m.
Personalizing endometrial cancer prevention through diet and lifestyle - News-Medical
Personalizing endometrial cancer prevention through diet and lifestyle News-Medical
Published: Aug. 7, 2025, 6:36 p.m.
(PDF) Nomogram Incorporating Inflammatory Index, Pathology, and Molecular Classification for Predicting Recurrence in Patients with Stage I-III Endometrial Cancer: A Multi-Institutional Study - researchgate.net
(PDF) Nomogram Incorporating Inflammatory Index, Pathology, and Molecular Classification for Predicting Recurrence in Patients with Stage I-III Endometrial Cancer: A Multi-Institutional Study researchgate.net
Published: Aug. 7, 2025, 4:27 p.m.
GSK’s New Clinical Study on Endometrial Cancer: What Investors Need to Know - TipRanks
GSK’s New Clinical Study on Endometrial Cancer: What Investors Need to Know TipRanks
Published: Aug. 7, 2025, 4:23 p.m.
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer - TipRanks
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer TipRanks
Published: Aug. 7, 2025, 4:18 p.m.
Dietary and lifestyle strategies for endometrial cancer prevention: Emerging evidence and unanswered questions - EurekAlert!
Dietary and lifestyle strategies for endometrial cancer prevention: Emerging evidence and unanswered questions EurekAlert!
Published: Aug. 7, 2025, 3:02 p.m.
Immunotherapy plus chemotherapy approved for endometrial cancer - The Pharmaceutical Journal
Immunotherapy plus chemotherapy approved for endometrial cancer The Pharmaceutical Journal
Published: Aug. 7, 2025, 2:48 p.m.
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes
NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes
Published: Aug. 7, 2025, 9:15 a.m.
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis - Frontiers
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis Frontiers
Published: Aug. 7, 2025, 7:56 a.m.
Link copied to clipboard!